Cargando…

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model

Background: Hypertrophic cardiomyopathy (HCM) patients often present with diastolic dysfunction and a normal to supranormal systolic function. To counteract this hypercontractility, guideline therapies advocate treatment with beta-adrenoceptor and Ca(2+) channel blockers. One well established pathom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stücker, Sabrina, Kresin, Nico, Carrier, Lucie, Friedrich, Felix W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539082/ https://www.ncbi.nlm.nih.gov/pubmed/28824454 http://dx.doi.org/10.3389/fphys.2017.00558

Ejemplares similares

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
por: Kresin, Nico, et al.
Publicado: (2019)

Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
por: Friedrich, Felix W., et al.
Publicado: (2016)

Dystrophic cardiomyopathy: role of the cardiac myofilaments
por: George, Thomas G., et al.
Publicado: (2023)

Modifications of Sarcoplasmic Reticulum Function Prevent Progression of Sarcomere-Linked Hypertrophic Cardiomyopathy Despite a Persistent Increase in Myofilament Calcium Response
por: Chowdhury, Shamim A. K., et al.
Publicado: (2020)

Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy
por: Schlossarek, Saskia, et al.
Publicado: (2014)

Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations
por: Sparrow, Alexander J., et al.
Publicado: (2019)

S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue
por: Braumann, Simon, et al.
Publicado: (2018)

Predicting Effects of Tropomyosin Mutations on Cardiac Muscle Contraction through Myofilament Modeling
por: Sewanan, Lorenzo R., et al.
Publicado: (2016)

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy
por: Prondzynski, Maksymilian, et al.
Publicado: (2019)

Molecular Defects in Cardiac Myofilament Ca(2+)-Regulation Due to Cardiomyopathy-Linked Mutations Can Be Reversed by Small Molecules Binding to Troponin
por: Sheehan, Alice, et al.
Publicado: (2018)

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Kawana, Masataka, et al.
Publicado: (2022)

Myofilament Calcium Sensitivity: Consequences of the Effective Concentration of Troponin I
por: Siddiqui, Jalal K., et al.
Publicado: (2016)

Regulation of Myofilament Contractile Function in Human Donor and Failing Hearts
por: McDonald, Kerry S., et al.
Publicado: (2020)

Inorganic phosphate accelerates cardiac myofilament relaxation in response to lengthening
por: Wakefield, Jane I., et al.
Publicado: (2022)

Staurosporine Inhibits Frequency-Dependent Myofilament Desensitization in Intact Rabbit Cardiac Trabeculae
por: Varian, Kenneth D., et al.
Publicado: (2012)

Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Frontiers Production Office,
Publicado: (2022)

Acute exercise modifies titin phosphorylation and increases cardiac myofilament stiffness
por: Müller, Anna E., et al.
Publicado: (2014)

Myofilament Calcium Sensitivity: Role in Regulation of In vivo Cardiac Contraction and Relaxation
por: Chung, Jae-Hoon, et al.
Publicado: (2016)

Modifications of myofilament protein phosphorylation and function in response to cardiac arrest induced in a swine model
por: Woodward, Mike, et al.
Publicado: (2015)

Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy
por: Ku, Min-Chi, et al.
Publicado: (2021)

Ion Channel Impairment and Myofilament Ca(2+) Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy
por: Santini, Lorenzo, et al.
Publicado: (2021)

ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study)
por: Güçlü, A., et al.
Publicado: (2013)

Hypertrophic cardiomyopathy: a heart in need of an energy bar?
por: Vakrou, Styliani, et al.
Publicado: (2014)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
por: Despond, Evan A., et al.
Publicado: (2018)

Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
por: Mekhaimar, Menatalla, et al.
Publicado: (2022)

Cardiac Myosin Binding Protein-C Phosphorylation Modulates Myofilament Length-Dependent Activation
por: Mamidi, Ranganath, et al.
Publicado: (2016)

Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy
por: Farrell, Emily T., et al.
Publicado: (2017)

FHL2 expression and variants in hypertrophic cardiomyopathy
por: Friedrich, Felix W., et al.
Publicado: (2014)

Why Is there a Limit to the Changes in Myofilament Ca(2+)-Sensitivity Associated with Myopathy Causing Mutations?
por: Marston, Steven B.
Publicado: (2016)

Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca(2+) flux caused by thin filament hypertrophic cardiomyopathy mutations
por: Sparrow, Alexander J., et al.
Publicado: (2020)

Carbonic Anhydrase III Is Expressed in Mouse Skeletal Muscles Independent of Fiber Type-Specific Myofilament Protein Isoforms and Plays a Role in Fatigue Resistance
por: Feng, Han-Zhong, et al.
Publicado: (2016)

Image-Based Computational Hemodynamics Analysis of Systolic Obstruction in Hypertrophic Cardiomyopathy
por: Fumagalli, Ivan, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation
por: Chalovich, J. M., et al.
Publicado: (2022)

Impaired Myofilament Contraction Drives Right Ventricular Failure Secondary to Pressure Overload: Model Simulations, Experimental Validation, and Treatment Predictions
por: Philip, Jennifer L., et al.
Publicado: (2018)

Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C
por: Patel, Bindiya G., et al.
Publicado: (2013)

A Transgenic Mouse Model of Eccentric Left Ventricular Hypertrophy With Preserved Ejection Fraction Exhibits Alterations in the Autophagy-Lysosomal Pathway
por: Wenzel, Kristin, et al.
Publicado: (2021)

Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants
por: Kraker, Jessica, et al.
Publicado: (2016)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Altered Ca(2+) and Na(+) Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis
por: Coppini, Raffaele, et al.
Publicado: (2018)

Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D
por: Herwig, Melissa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pe9bqfqmcu4jit7v68bqpsl90b